#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Roles of Bacterial Virulence Factors During Invasion Through the Barriers of the CNS
1-1	0-2	4.	_	_	_	_
1-2	3-8	Roles	abstract[1]	new[1]	_	_
1-3	9-11	of	abstract[1]	new[1]	_	_
1-4	12-21	Bacterial	abstract[1]|abstract[3]	new[1]|new[3]	coref	2-12[10_3]
1-5	22-31	Virulence	abstract[1]|abstract|abstract[3]	new[1]|new|new[3]	coref	2-13
1-6	32-39	Factors	abstract[1]|abstract[3]	new[1]|new[3]	_	_
1-7	40-46	During	abstract[1]	new[1]	_	_
1-8	47-55	Invasion	abstract[1]|event[4]	new[1]|new[4]	coref	5-8[21_4]
1-9	56-63	Through	abstract[1]|event[4]	new[1]|new[4]	_	_
1-10	64-67	the	abstract[1]|event[4]|object[5]	new[1]|new[4]|new[5]	coref	12-23[67_5]
1-11	68-76	Barriers	abstract[1]|event[4]|object[5]	new[1]|new[4]|new[5]	_	_
1-12	77-79	of	abstract[1]|event[4]|object[5]	new[1]|new[4]|new[5]	_	_
1-13	80-83	the	abstract[1]|event[4]|object[5]|abstract[6]	new[1]|new[4]|new[5]|new[6]	coref	2-6[7_6]
1-14	84-87	CNS	abstract[1]|event[4]|object[5]|abstract[6]	new[1]|new[4]|new[5]|new[6]	_	_

#Text=To be able to enter the CNS , bacterial pathogens use several virulence factors , which are involved in the different steps of pathogenesis .
2-1	88-90	To	_	_	_	_
2-2	91-93	be	_	_	_	_
2-3	94-98	able	_	_	_	_
2-4	99-101	to	_	_	_	_
2-5	102-107	enter	_	_	_	_
2-6	108-111	the	abstract[7]	giv[7]	coref	20-17[103_7]
2-7	112-115	CNS	abstract[7]	giv[7]	_	_
2-8	116-117	,	_	_	_	_
2-9	118-127	bacterial	animal[8]	new[8]	coref	7-8[0_8]
2-10	128-137	pathogens	animal[8]	new[8]	_	_
2-11	138-141	use	_	_	_	_
2-12	142-149	several	abstract[10]	giv[10]	coref	8-8[46_10]
2-13	150-159	virulence	abstract|abstract[10]	giv|giv[10]	coref	8-9
2-14	160-167	factors	abstract[10]	giv[10]	_	_
2-15	168-169	,	abstract[10]	giv[10]	_	_
2-16	170-175	which	abstract[10]	giv[10]	_	_
2-17	176-179	are	abstract[10]	giv[10]	_	_
2-18	180-188	involved	abstract[10]	giv[10]	_	_
2-19	189-191	in	abstract[10]	giv[10]	_	_
2-20	192-195	the	abstract[10]|abstract[11]	giv[10]|new[11]	_	_
2-21	196-205	different	abstract[10]|abstract[11]	giv[10]|new[11]	_	_
2-22	206-211	steps	abstract[10]|abstract[11]	giv[10]|new[11]	_	_
2-23	212-214	of	abstract[10]|abstract[11]	giv[10]|new[11]	_	_
2-24	215-227	pathogenesis	abstract[10]|abstract[11]|abstract	giv[10]|new[11]|new	_	_
2-25	228-229	.	_	_	_	_

#Text=Of major importance is the capsule of both gram-positive and gram-negative bacteria .
3-1	230-232	Of	_	_	_	_
3-2	233-238	major	abstract[13]	new[13]	_	_
3-3	239-249	importance	abstract[13]	new[13]	_	_
3-4	250-252	is	_	_	_	_
3-5	253-256	the	object[14]	new[14]	coref	7-4[31_14]
3-6	257-264	capsule	object[14]	new[14]	_	_
3-7	265-267	of	object[14]	new[14]	_	_
3-8	268-272	both	object[14]|animal[15]	new[14]|new[15]	coref	8-14[47_15]
3-9	273-286	gram-positive	object[14]|animal[15]	new[14]|new[15]	_	_
3-10	287-290	and	object[14]|animal[15]	new[14]|new[15]	_	_
3-11	291-304	gram-negative	object[14]|animal[15]	new[14]|new[15]	_	_
3-12	305-313	bacteria	object[14]|animal[15]	new[14]|new[15]	_	_
3-13	314-315	.	_	_	_	_

#Text=The capsular polysaccharide has a protective function in bloodstream survival .
4-1	316-319	The	substance[16]	new[16]	_	_
4-2	320-328	capsular	substance[16]	new[16]	_	_
4-3	329-343	polysaccharide	substance[16]	new[16]	_	_
4-4	344-347	has	_	_	_	_
4-5	348-349	a	abstract[17]	new[17]	ana	5-3[0_17]
4-6	350-360	protective	abstract[17]	new[17]	_	_
4-7	361-369	function	abstract[17]	new[17]	_	_
4-8	370-372	in	abstract[17]	new[17]	_	_
4-9	373-384	bloodstream	abstract[17]|substance|event[19]	new[17]|new|new[19]	coref	7-7[33_19]
4-10	385-393	survival	abstract[17]|event[19]	new[17]|new[19]	_	_
4-11	394-395	.	_	_	_	_

#Text=However , it was observed to attenuate invasion of the BBB and BCSFB .
5-1	396-403	However	_	_	_	_
5-2	404-405	,	_	_	_	_
5-3	406-408	it	abstract	giv	_	_
5-4	409-412	was	_	_	_	_
5-5	413-421	observed	_	_	_	_
5-6	422-424	to	_	_	_	_
5-7	425-434	attenuate	_	_	_	_
5-8	435-443	invasion	event[21]	giv[21]	ana	6-1[0_21]
5-9	444-446	of	event[21]	giv[21]	_	_
5-10	447-450	the	event[21]|abstract[22]|abstract[23]	giv[21]|new[22]|new[23]	coref|coref	17-13[84_22]|17-13[85_23]
5-11	451-454	BBB	event[21]|abstract[22]|abstract[23]	giv[21]|new[22]|new[23]	_	_
5-12	455-458	and	event[21]|abstract[23]	giv[21]|new[23]	_	_
5-13	459-464	BCSFB	event[21]|abstract[23]|abstract	giv[21]|new[23]|new	coref	17-16
5-14	465-466	.	_	_	_	_

#Text=This could result from electrostatic repulsion or from the masking of bacterial surface structures .
6-1	467-471	This	event	giv	coref	25-14[145_0]
6-2	472-477	could	_	_	_	_
6-3	478-484	result	_	_	_	_
6-4	485-489	from	_	_	_	_
6-5	490-503	electrostatic	abstract[26]	new[26]	_	_
6-6	504-513	repulsion	abstract[26]	new[26]	_	_
6-7	514-516	or	_	_	_	_
6-8	517-521	from	_	_	_	_
6-9	522-525	the	abstract[27]	new[27]	_	_
6-10	526-533	masking	abstract[27]	new[27]	_	_
6-11	534-536	of	abstract[27]	new[27]	_	_
6-12	537-546	bacterial	abstract[27]|object[29]	new[27]|new[29]	_	_
6-13	547-554	surface	abstract[27]|place|object[29]	new[27]|new|new[29]	coref	26-12
6-14	555-565	structures	abstract[27]|object[29]	new[27]|new[29]	_	_
6-15	566-567	.	_	_	_	_

#Text=The necessity of the capsule for the pathogens survival in the blood but simultaneous hindrance of invasion of the host ’s tissues indicates a need for the regulation of capsule expression .
7-1	568-571	The	abstract[30]	new[30]	_	_
7-2	572-581	necessity	abstract[30]	new[30]	_	_
7-3	582-584	of	abstract[30]	new[30]	_	_
7-4	585-588	the	abstract[30]|object[31]	new[30]|giv[31]	coref	7-30[0_31]
7-5	589-596	capsule	abstract[30]|object[31]	new[30]|giv[31]	_	_
7-6	597-600	for	abstract[30]	new[30]	_	_
7-7	601-604	the	abstract[30]|event[33]	new[30]|giv[33]	_	_
7-8	605-614	pathogens	abstract[30]|animal|event[33]	new[30]|giv|giv[33]	_	_
7-9	615-623	survival	abstract[30]|event[33]	new[30]|giv[33]	_	_
7-10	624-626	in	abstract[30]|event[33]	new[30]|giv[33]	_	_
7-11	627-630	the	abstract[30]|event[33]|substance[34]	new[30]|giv[33]|new[34]	coref	12-24[0_34]
7-12	631-636	blood	abstract[30]|event[33]|substance[34]	new[30]|giv[33]|new[34]	_	_
7-13	637-640	but	_	_	_	_
7-14	641-653	simultaneous	abstract[35]	new[35]	_	_
7-15	654-663	hindrance	abstract[35]	new[35]	_	_
7-16	664-666	of	abstract[35]	new[35]	_	_
7-17	667-675	invasion	abstract[35]|event[36]	new[35]|new[36]	coref	23-4[0_36]
7-18	676-678	of	abstract[35]|event[36]	new[35]|new[36]	_	_
7-19	679-682	the	abstract[35]|event[36]|object[38]	new[35]|new[36]|new[38]	_	_
7-20	683-687	host	abstract[35]|event[36]|animal[37]|object[38]	new[35]|new[36]|new[37]|new[38]	coref	18-9[90_37]
7-21	688-690	’s	abstract[35]|event[36]|animal[37]|object[38]	new[35]|new[36]|new[37]|new[38]	_	_
7-22	691-698	tissues	abstract[35]|event[36]|object[38]	new[35]|new[36]|new[38]	_	_
7-23	699-708	indicates	_	_	_	_
7-24	709-710	a	abstract[39]	new[39]	_	_
7-25	711-715	need	abstract[39]	new[39]	_	_
7-26	716-719	for	abstract[39]	new[39]	_	_
7-27	720-723	the	abstract[39]|abstract[40]	new[39]|new[40]	_	_
7-28	724-734	regulation	abstract[39]|abstract[40]	new[39]|new[40]	_	_
7-29	735-737	of	abstract[39]|abstract[40]	new[39]|new[40]	_	_
7-30	738-745	capsule	abstract[39]|abstract[40]|object|abstract[42]	new[39]|new[40]|giv|new[42]	coref	8-2[43_0]
7-31	746-756	expression	abstract[39]|abstract[40]|abstract[42]	new[39]|new[40]|new[42]	_	_
7-32	757-758	.	_	_	_	_

#Text=Besides the capsule , a multitude of further virulence factors are used by gram-positive and gram-negative bacteria .
8-1	759-766	Besides	_	_	_	_
8-2	767-770	the	object[43]	giv[43]	_	_
8-3	771-778	capsule	object[43]	giv[43]	_	_
8-4	779-780	,	_	_	_	_
8-5	781-782	a	abstract[44]	new[44]	_	_
8-6	783-792	multitude	abstract[44]	new[44]	_	_
8-7	793-795	of	abstract[44]	new[44]	_	_
8-8	796-803	further	abstract[44]|abstract[46]	new[44]|giv[46]	ana	9-1[0_46]
8-9	804-813	virulence	abstract[44]|abstract|abstract[46]	new[44]|giv|giv[46]	coref	12-10
8-10	814-821	factors	abstract[44]|abstract[46]	new[44]|giv[46]	_	_
8-11	822-825	are	_	_	_	_
8-12	826-830	used	_	_	_	_
8-13	831-833	by	_	_	_	_
8-14	834-847	gram-positive	animal[47]	giv[47]	coref	13-8[71_47]
8-15	848-851	and	animal[47]	giv[47]	_	_
8-16	852-865	gram-negative	animal[47]	giv[47]	_	_
8-17	866-874	bacteria	animal[47]	giv[47]	_	_
8-18	875-876	.	_	_	_	_

#Text=These include , among others , adhesins and internalins , pore-forming toxins , and factors involved in intracellular movement as well as cell-to cell spread and are summarized in
9-1	877-882	These	abstract	giv	coref	9-15[52_0]
9-2	883-890	include	_	_	_	_
9-3	891-892	,	_	_	_	_
9-4	893-898	among	_	_	_	_
9-5	899-905	others	abstract[49]	new[49]	_	_
9-6	906-907	,	abstract[49]	new[49]	_	_
9-7	908-916	adhesins	abstract[49]	new[49]	_	_
9-8	917-920	and	_	_	_	_
9-9	921-932	internalins	substance	new	coref	25-8[144_0]
9-10	933-934	,	_	_	_	_
9-11	935-947	pore-forming	substance[51]	new[51]	_	_
9-12	948-954	toxins	substance[51]	new[51]	_	_
9-13	955-956	,	_	_	_	_
9-14	957-960	and	_	_	_	_
9-15	961-968	factors	abstract[52]	giv[52]	coref	12-10[60_52]
9-16	969-977	involved	abstract[52]	giv[52]	_	_
9-17	978-980	in	abstract[52]	giv[52]	_	_
9-18	981-994	intracellular	abstract[52]|event[53]	giv[52]|new[53]	_	_
9-19	995-1003	movement	abstract[52]|event[53]	giv[52]|new[53]	_	_
9-20	1004-1006	as	abstract[52]	giv[52]	_	_
9-21	1007-1011	well	abstract[52]	giv[52]	_	_
9-22	1012-1014	as	abstract[52]	giv[52]	_	_
9-23	1015-1022	cell-to	abstract[52]|place[54]|event[55]	giv[52]|new[54]|new[55]	coref	23-21[0_54]
9-24	1023-1027	cell	abstract[52]|place[54]|event[55]	giv[52]|new[54]|new[55]	_	_
9-25	1028-1034	spread	abstract[52]|event[55]	giv[52]|new[55]	_	_
9-26	1035-1038	and	_	_	_	_
9-27	1039-1042	are	_	_	_	_
9-28	1043-1053	summarized	_	_	_	_
9-29	1054-1056	in	_	_	_	_

#Text=Figure 2
10-1	1057-1063	Figure	abstract[56]	new[56]	_	_
10-2	1064-1065	2	abstract[56]	new[56]	_	_

#Text=.
11-1	1066-1067	.	_	_	_	_

#Text=In this review , we will focus particularly on virulence factors , for which evidence for an involvement during brain entry across the blood – brain barriers has been proposed .
12-1	1068-1070	In	_	_	_	_
12-2	1071-1075	this	abstract[57]	new[57]	_	_
12-3	1076-1082	review	abstract[57]	new[57]	_	_
12-4	1083-1084	,	_	_	_	_
12-5	1085-1087	we	person	acc	_	_
12-6	1088-1092	will	_	_	_	_
12-7	1093-1098	focus	_	_	_	_
12-8	1099-1111	particularly	_	_	_	_
12-9	1112-1114	on	_	_	_	_
12-10	1115-1124	virulence	abstract|abstract[60]	giv|giv[60]	coref|coref	13-5|13-4[70_60]
12-11	1125-1132	factors	abstract[60]	giv[60]	_	_
12-12	1133-1134	,	abstract[60]	giv[60]	_	_
12-13	1135-1138	for	abstract[60]	giv[60]	_	_
12-14	1139-1144	which	abstract[60]	giv[60]	_	_
12-15	1145-1153	evidence	abstract[60]|abstract[61]	giv[60]|new[61]	_	_
12-16	1154-1157	for	abstract[60]|abstract[61]	giv[60]|new[61]	_	_
12-17	1158-1160	an	abstract[60]|abstract[61]|abstract[62]	giv[60]|new[61]|new[62]	coref	29-24[181_62]
12-18	1161-1172	involvement	abstract[60]|abstract[61]|abstract[62]	giv[60]|new[61]|new[62]	_	_
12-19	1173-1179	during	abstract[60]|abstract[61]|abstract[62]	giv[60]|new[61]|new[62]	_	_
12-20	1180-1185	brain	abstract[60]|abstract[61]|abstract[62]|object|event[64]	giv[60]|new[61]|new[62]|new|new[64]	coref|coref	12-26|28-21[170_64]
12-21	1186-1191	entry	abstract[60]|abstract[61]|abstract[62]|event[64]	giv[60]|new[61]|new[62]|new[64]	_	_
12-22	1192-1198	across	abstract[60]|abstract[61]|abstract[62]|event[64]	giv[60]|new[61]|new[62]|new[64]	_	_
12-23	1199-1202	the	abstract[60]|abstract[61]|abstract[62]|event[64]|object[67]	giv[60]|new[61]|new[62]|new[64]|giv[67]	coref	17-4[82_67]
12-24	1203-1208	blood	abstract[60]|abstract[61]|abstract[62]|event[64]|substance|object[67]	giv[60]|new[61]|new[62]|new[64]|giv|giv[67]	coref	19-25
12-25	1209-1210	–	abstract[60]|abstract[61]|abstract[62]|event[64]|object[67]	giv[60]|new[61]|new[62]|new[64]|giv[67]	_	_
12-26	1211-1216	brain	abstract[60]|abstract[61]|abstract[62]|event[64]|object|object[67]	giv[60]|new[61]|new[62]|new[64]|giv|giv[67]	coref	17-10[83_0]
12-27	1217-1225	barriers	abstract[60]|abstract[61]|abstract[62]|event[64]|object[67]	giv[60]|new[61]|new[62]|new[64]|giv[67]	_	_
12-28	1226-1229	has	abstract[60]	giv[60]	_	_
12-29	1230-1234	been	abstract[60]	giv[60]	_	_
12-30	1235-1243	proposed	abstract[60]	giv[60]	_	_
12-31	1244-1245	.	_	_	_	_

#Text=A summary of these virulence factors for gram-positive and gram-negative bacteria is given in Table 1 at the end of this section .
13-1	1246-1247	A	abstract[68]	new[68]	_	_
13-2	1248-1255	summary	abstract[68]	new[68]	_	_
13-3	1256-1258	of	abstract[68]	new[68]	_	_
13-4	1259-1264	these	abstract[68]|abstract[70]	new[68]|giv[70]	coref	32-7[199_70]
13-5	1265-1274	virulence	abstract[68]|abstract|abstract[70]	new[68]|giv|giv[70]	_	_
13-6	1275-1282	factors	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
13-7	1283-1286	for	abstract[68]|abstract[70]	new[68]|giv[70]	_	_
13-8	1287-1300	gram-positive	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
13-9	1301-1304	and	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
13-10	1305-1318	gram-negative	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
13-11	1319-1327	bacteria	abstract[68]|abstract[70]|animal[71]	new[68]|giv[70]|giv[71]	_	_
13-12	1328-1330	is	_	_	_	_
13-13	1331-1336	given	_	_	_	_
13-14	1337-1339	in	_	_	_	_
13-15	1340-1345	Table	abstract[72]	new[72]	_	_
13-16	1346-1347	1	abstract[72]	new[72]	_	_
13-17	1348-1350	at	_	_	_	_
13-18	1351-1354	the	time[73]	new[73]	_	_
13-19	1355-1358	end	time[73]	new[73]	_	_
13-20	1359-1361	of	time[73]	new[73]	_	_
13-21	1362-1366	this	time[73]|abstract[74]	new[73]|new[74]	_	_
13-22	1367-1374	section	time[73]|abstract[74]	new[73]|new[74]	_	_
13-23	1375-1376	.	_	_	_	_

#Text=4.1. Gram-Positive Bacteria
14-1	1377-1381	4.1.	_	_	_	_
14-2	1382-1395	Gram-Positive	person|substance[76]	new|new[76]	_	_
14-3	1396-1404	Bacteria	substance[76]	new[76]	_	_

#Text=4.1.1. Listeria Monocytogenes
15-1	1405-1411	4.1.1.	_	_	_	_
15-2	1412-1420	Listeria	person[77]	new[77]	coref	16-1[78_77]
15-3	1421-1434	Monocytogenes	person[77]	new[77]	_	_

#Text=Listeria monocytogenes ( L. monocytogenes ) is a facultative intracellular gram-positive bacterium .
16-1	1435-1443	Listeria	person[78]	giv[78]	appos	16-4[79_78]
16-2	1444-1457	monocytogenes	person[78]	giv[78]	_	_
16-3	1458-1459	(	_	_	_	_
16-4	1460-1462	L.	person[79]	giv[79]	coref	16-8[80_79]
16-5	1463-1476	monocytogenes	person[79]	giv[79]	_	_
16-6	1477-1478	)	_	_	_	_
16-7	1479-1481	is	_	_	_	_
16-8	1482-1483	a	person[80]	giv[80]	ana	17-1[0_80]
16-9	1484-1495	facultative	person[80]	giv[80]	_	_
16-10	1496-1509	intracellular	person[80]	giv[80]	_	_
16-11	1510-1523	gram-positive	person[80]	giv[80]	_	_
16-12	1524-1533	bacterium	person[80]	giv[80]	_	_
16-13	1534-1535	.	_	_	_	_

#Text=It can traverse several physiological barriers and finally enter the brain via the BBB or BCSFB , especially in immunocompromised individuals .
17-1	1536-1538	It	person	giv	coref	19-4[91_0]
17-2	1539-1542	can	_	_	_	_
17-3	1543-1551	traverse	event	new	none|none	17-3[0_183]|19-6
17-4	1552-1559	several	object[82]	giv[82]	_	_
17-5	1560-1573	physiological	object[82]	giv[82]	_	_
17-6	1574-1582	barriers	object[82]	giv[82]	_	_
17-7	1583-1586	and	_	_	_	_
17-8	1587-1594	finally	_	_	_	_
17-9	1595-1600	enter	_	_	_	_
17-10	1601-1604	the	object[83]	giv[83]	coref	20-23[105_83]
17-11	1605-1610	brain	object[83]	giv[83]	_	_
17-12	1611-1614	via	_	_	_	_
17-13	1615-1618	the	abstract[84]|abstract[85]	giv[84]|giv[85]	coref|coref	21-7[107_84]|21-7[108_85]
17-14	1619-1622	BBB	abstract[84]|abstract[85]	giv[84]|giv[85]	_	_
17-15	1623-1625	or	abstract[85]	giv[85]	_	_
17-16	1626-1631	BCSFB	abstract[85]|abstract	giv[85]|giv	ana	18-1
17-17	1632-1633	,	_	_	_	_
17-18	1634-1644	especially	animal[87]	new[87]	_	_
17-19	1645-1647	in	animal[87]	new[87]	_	_
17-20	1648-1665	immunocompromised	animal[87]	new[87]	_	_
17-21	1666-1677	individuals	animal[87]	new[87]	_	_
17-22	1678-1679	.	_	_	_	_

#Text=It is ingested through highly contaminated food by the host .
18-1	1680-1682	It	abstract	giv	coref	21-10
18-2	1683-1685	is	_	_	_	_
18-3	1686-1694	ingested	_	_	_	_
18-4	1695-1702	through	_	_	_	_
18-5	1703-1709	highly	substance[89]	new[89]	_	_
18-6	1710-1722	contaminated	substance[89]	new[89]	_	_
18-7	1723-1727	food	substance[89]	new[89]	_	_
18-8	1728-1730	by	_	_	_	_
18-9	1731-1734	the	animal[90]	giv[90]	coref	22-10[119_90]
18-10	1735-1739	host	animal[90]	giv[90]	_	_
18-11	1740-1741	.	_	_	_	_

#Text=Once ingested , L. monocytogenes traverses the intestinal epithelial barrier into the lamina propria followed by dissemination of the pathogen via the lymph and blood .
19-1	1742-1746	Once	_	_	_	_
19-2	1747-1755	ingested	_	_	_	_
19-3	1756-1757	,	_	_	_	_
19-4	1758-1760	L.	person[91]	giv[91]	coref	20-1[99_91]
19-5	1761-1774	monocytogenes	person[91]	giv[91]	_	_
19-6	1775-1784	traverses	event	new	coref	29-27[183_0]
19-7	1785-1788	the	object[92]	new[92]	_	_
19-8	1789-1799	intestinal	object[92]	new[92]	_	_
19-9	1800-1810	epithelial	object[92]	new[92]	_	_
19-10	1811-1818	barrier	object[92]	new[92]	_	_
19-11	1819-1823	into	_	_	_	_
19-12	1824-1827	the	place[93]|place[94]	new[93]|new[94]	_	_
19-13	1828-1834	lamina	place[93]|place[94]	new[93]|new[94]	_	_
19-14	1835-1842	propria	place[94]	new[94]	_	_
19-15	1843-1851	followed	_	_	_	_
19-16	1852-1854	by	_	_	_	_
19-17	1855-1868	dissemination	event[95]	new[95]	_	_
19-18	1869-1871	of	event[95]	new[95]	_	_
19-19	1872-1875	the	event[95]|substance[96]	new[95]|new[96]	coref	24-7[141_96]
19-20	1876-1884	pathogen	event[95]|substance[96]	new[95]|new[96]	_	_
19-21	1885-1888	via	event[95]	new[95]	_	_
19-22	1889-1892	the	event[95]|substance[97]	new[95]|new[97]	_	_
19-23	1893-1898	lymph	event[95]|substance[97]	new[95]|new[97]	_	_
19-24	1899-1902	and	event[95]	new[95]	_	_
19-25	1903-1908	blood	event[95]|substance	new[95]|giv	_	_
19-26	1909-1910	.	_	_	_	_

#Text=L. monocytogenes has multiple target organs , including the liver and spleen , and can enter the CNS across the barriers of the brain .
20-1	1911-1913	L.	person[99]	giv[99]	coref	22-1[117_99]
20-2	1914-1927	monocytogenes	person[99]	giv[99]	_	_
20-3	1928-1931	has	_	_	_	_
20-4	1932-1940	multiple	object[100]	new[100]	_	_
20-5	1941-1947	target	object[100]	new[100]	_	_
20-6	1948-1954	organs	object[100]	new[100]	_	_
20-7	1955-1956	,	object[100]	new[100]	_	_
20-8	1957-1966	including	object[100]	new[100]	_	_
20-9	1967-1970	the	object[100]|object[101]	new[100]|new[101]	_	_
20-10	1971-1976	liver	object[100]|object[101]	new[100]|new[101]	_	_
20-11	1977-1980	and	object[100]	new[100]	_	_
20-12	1981-1987	spleen	object[100]|abstract	new[100]|new	_	_
20-13	1988-1989	,	_	_	_	_
20-14	1990-1993	and	_	_	_	_
20-15	1994-1997	can	_	_	_	_
20-16	1998-2003	enter	_	_	_	_
20-17	2004-2007	the	abstract[103]	giv[103]	_	_
20-18	2008-2011	CNS	abstract[103]	giv[103]	_	_
20-19	2012-2018	across	_	_	_	_
20-20	2019-2022	the	object[104]	new[104]	_	_
20-21	2023-2031	barriers	object[104]	new[104]	_	_
20-22	2032-2034	of	object[104]	new[104]	_	_
20-23	2035-2038	the	object[104]|object[105]	new[104]|giv[105]	coref	26-29[157_105]
20-24	2039-2044	brain	object[104]|object[105]	new[104]|giv[105]	_	_
20-25	2045-2046	.	_	_	_	_

#Text=In addition to direct traversal of the BBB and BCSFB via the transcellular route , transportation across the BBB within leukocytes and retrograde migration within axons of cranial nerves have been described .
21-1	2047-2049	In	_	_	_	_
21-2	2050-2058	addition	_	_	_	_
21-3	2059-2061	to	_	_	_	_
21-4	2062-2068	direct	event[106]	new[106]	_	_
21-5	2069-2078	traversal	event[106]	new[106]	_	_
21-6	2079-2081	of	event[106]	new[106]	_	_
21-7	2082-2085	the	event[106]|abstract[107]|abstract[108]	new[106]|giv[107]|giv[108]	coref|coref	21-18[112_107]|25-16[147_108]
21-8	2086-2089	BBB	event[106]|abstract[107]|abstract[108]	new[106]|giv[107]|giv[108]	_	_
21-9	2090-2093	and	event[106]|abstract[108]	new[106]|giv[108]	_	_
21-10	2094-2099	BCSFB	event[106]|abstract[108]|abstract	new[106]|giv[108]|giv	coref	25-19
21-11	2100-2103	via	event[106]	new[106]	_	_
21-12	2104-2107	the	event[106]|abstract[110]	new[106]|new[110]	_	_
21-13	2108-2121	transcellular	event[106]|abstract[110]	new[106]|new[110]	_	_
21-14	2122-2127	route	event[106]|abstract[110]	new[106]|new[110]	_	_
21-15	2128-2129	,	_	_	_	_
21-16	2130-2144	transportation	event[111]	new[111]	_	_
21-17	2145-2151	across	event[111]	new[111]	_	_
21-18	2152-2155	the	event[111]|abstract[112]	new[111]|giv[112]	coref	25-16[146_112]
21-19	2156-2159	BBB	event[111]|abstract[112]	new[111]|giv[112]	_	_
21-20	2160-2166	within	event[111]	new[111]	_	_
21-21	2167-2177	leukocytes	event[111]|substance	new[111]|new	_	_
21-22	2178-2181	and	_	_	_	_
21-23	2182-2192	retrograde	event[114]	new[114]	_	_
21-24	2193-2202	migration	event[114]	new[114]	_	_
21-25	2203-2209	within	event[114]	new[114]	_	_
21-26	2210-2215	axons	event[114]|object[115]	new[114]|new[115]	_	_
21-27	2216-2218	of	event[114]|object[115]	new[114]|new[115]	_	_
21-28	2219-2226	cranial	event[114]|object[115]|object[116]	new[114]|new[115]|new[116]	_	_
21-29	2227-2233	nerves	event[114]|object[115]|object[116]	new[114]|new[115]|new[116]	_	_
21-30	2234-2238	have	_	_	_	_
21-31	2239-2243	been	_	_	_	_
21-32	2244-2253	described	_	_	_	_
21-33	2254-2255	.	_	_	_	_

#Text=L. monocytogenes can enter non-phagocytotic cells by hijacking the host ’s receptor-mediated endocytosis machinery using the zipper mechanism .
22-1	2256-2258	L.	person[117]	giv[117]	coref	23-7[0_117]
22-2	2259-2272	monocytogenes	person[117]	giv[117]	_	_
22-3	2273-2276	can	_	_	_	_
22-4	2277-2282	enter	_	_	_	_
22-5	2283-2299	non-phagocytotic	object[118]	new[118]	coref	28-10[166_118]
22-6	2300-2305	cells	object[118]	new[118]	_	_
22-7	2306-2308	by	_	_	_	_
22-8	2309-2318	hijacking	_	_	_	_
22-9	2319-2322	the	object[121]	new[121]	coref	30-16[192_121]
22-10	2323-2327	host	animal[119]|object[121]	giv[119]|new[121]	coref	37-4[0_119]
22-11	2328-2330	’s	animal[119]|object[121]	giv[119]|new[121]	_	_
22-12	2331-2348	receptor-mediated	object[121]	new[121]	_	_
22-13	2349-2360	endocytosis	abstract|object[121]	new|new[121]	coref	24-4[140_0]
22-14	2361-2370	machinery	object[121]	new[121]	_	_
22-15	2371-2376	using	_	_	_	_
22-16	2377-2380	the	event[123]	new[123]	coref	19-6[0_123]
22-17	2381-2387	zipper	person|event[123]	new|new[123]	_	_
22-18	2388-2397	mechanism	event[123]	new[123]	_	_
22-19	2398-2399	.	_	_	_	_

#Text=The two major invasion proteins of L. monocytogenes are internalin ( InlA ) and InlB , which bind to eukaryotic cell membrane members E-cadherin and tyrosine kinase receptor protein Met , respectively .
23-1	2400-2403	The	substance[125]	new[125]	_	_
23-2	2404-2407	two	substance[125]	new[125]	_	_
23-3	2408-2413	major	substance[125]	new[125]	_	_
23-4	2414-2422	invasion	event|substance[125]	giv|new[125]	_	_
23-5	2423-2431	proteins	substance[125]	new[125]	_	_
23-6	2432-2434	of	substance[125]	new[125]	_	_
23-7	2435-2437	L.	substance[125]|person|person[127]	new[125]|giv|giv[127]	coref|coref	23-7[127_0]|25-1[0_127]
23-8	2438-2451	monocytogenes	substance[125]|person[127]	new[125]|giv[127]	_	_
23-9	2452-2455	are	_	_	_	_
23-10	2456-2466	internalin	_	_	_	_
23-11	2467-2468	(	_	_	_	_
23-12	2469-2473	InlA	abstract	new	_	_
23-13	2474-2475	)	_	_	_	_
23-14	2476-2479	and	_	_	_	_
23-15	2480-2484	InlB	abstract[129]	new[129]	_	_
23-16	2485-2486	,	abstract[129]	new[129]	_	_
23-17	2487-2492	which	abstract[129]	new[129]	_	_
23-18	2493-2497	bind	abstract[129]	new[129]	_	_
23-19	2498-2500	to	abstract[129]	new[129]	_	_
23-20	2501-2511	eukaryotic	abstract[129]|animal[132]	new[129]|new[132]	_	_
23-21	2512-2516	cell	abstract[129]|place|animal[132]	new[129]|giv|new[132]	coref	35-17
23-22	2517-2525	membrane	abstract[129]|object|animal[132]	new[129]|new|new[132]	coref	38-29
23-23	2526-2533	members	abstract[129]|animal[132]	new[129]|new[132]	_	_
23-24	2534-2544	E-cadherin	abstract[129]|animal[132]|abstract	new[129]|new[132]|new	coref	30-8
23-25	2545-2548	and	abstract[129]|animal[132]	new[129]|new[132]	_	_
23-26	2549-2557	tyrosine	abstract[129]|animal[132]|abstract|object[135]|substance[137]	new[129]|new[132]|new|new[135]|new[137]	coref|coref	26-10[152_137]|42-11[0_135]
23-27	2558-2564	kinase	abstract[129]|animal[132]|object[135]|substance[137]	new[129]|new[132]|new[135]|new[137]	_	_
23-28	2565-2573	receptor	abstract[129]|animal[132]|substance|substance[137]	new[129]|new[132]|new|new[137]	_	_
23-29	2574-2581	protein	abstract[129]|animal[132]|substance[137]	new[129]|new[132]|new[137]	_	_
23-30	2582-2585	Met	abstract[129]|animal[132]|object	new[129]|new[132]|new	coref	30-10
23-31	2586-2587	,	abstract[129]	new[129]	_	_
23-32	2588-2600	respectively	abstract[129]	new[129]	_	_
23-33	2601-2602	.	_	_	_	_

#Text=These interactions induce receptor-mediated endocytosis of the pathogen .
24-1	2603-2608	These	abstract[139]	new[139]	_	_
24-2	2609-2621	interactions	abstract[139]	new[139]	_	_
24-3	2622-2628	induce	_	_	_	_
24-4	2629-2646	receptor-mediated	abstract[140]	giv[140]	coref	30-18[0_140]
24-5	2647-2658	endocytosis	abstract[140]	giv[140]	_	_
24-6	2659-2661	of	abstract[140]	giv[140]	_	_
24-7	2662-2665	the	abstract[140]|substance[141]	giv[140]|giv[141]	coref	32-24[204_141]
24-8	2666-2674	pathogen	abstract[140]|substance[141]	giv[140]|giv[141]	_	_
24-9	2675-2676	.	_	_	_	_

#Text=L. monocytogenes has been demonstrated to use one or both internalins to mediate invasion of the BBB and BCSFB .
25-1	2677-2679	L.	person	giv	coref	25-2
25-2	2680-2693	monocytogenes	person	giv	coref	27-11[162_0]
25-3	2694-2697	has	_	_	_	_
25-4	2698-2702	been	_	_	_	_
25-5	2703-2715	demonstrated	_	_	_	_
25-6	2716-2718	to	_	_	_	_
25-7	2719-2722	use	_	_	_	_
25-8	2723-2726	one	substance[144]	giv[144]	_	_
25-9	2727-2729	or	substance[144]	giv[144]	_	_
25-10	2730-2734	both	substance[144]	giv[144]	_	_
25-11	2735-2746	internalins	substance[144]	giv[144]	_	_
25-12	2747-2749	to	_	_	_	_
25-13	2750-2757	mediate	_	_	_	_
25-14	2758-2766	invasion	event[145]	giv[145]	_	_
25-15	2767-2769	of	event[145]	giv[145]	_	_
25-16	2770-2773	the	event[145]|abstract[146]|abstract[147]	giv[145]|giv[146]|giv[147]	_	_
25-17	2774-2777	BBB	event[145]|abstract[146]|abstract[147]	giv[145]|giv[146]|giv[147]	_	_
25-18	2778-2781	and	event[145]|abstract[147]	giv[145]|giv[147]	_	_
25-19	2782-2787	BCSFB	event[145]|abstract[147]|abstract	giv[145]|giv[147]|giv	coref	28-6[164_0]
25-20	2788-2789	.	_	_	_	_

#Text=A recent study has further demonstrated the importance of the bacterial surface protein InlF , showing that interaction with surface vimentin was required for an optimal colonialization of the brain .
26-1	2790-2791	A	abstract[149]	new[149]	coref	33-3[206_149]
26-2	2792-2798	recent	abstract[149]	new[149]	_	_
26-3	2799-2804	study	abstract[149]	new[149]	_	_
26-4	2805-2808	has	_	_	_	_
26-5	2809-2816	further	_	_	_	_
26-6	2817-2829	demonstrated	_	_	_	_
26-7	2830-2833	the	abstract[150]	new[150]	_	_
26-8	2834-2844	importance	abstract[150]	new[150]	_	_
26-9	2845-2847	of	abstract[150]	new[150]	_	_
26-10	2848-2851	the	abstract[150]|substance[152]	new[150]|giv[152]	_	_
26-11	2852-2861	bacterial	abstract[150]|substance[152]	new[150]|giv[152]	_	_
26-12	2862-2869	surface	abstract[150]|place|substance[152]	new[150]|giv|giv[152]	coref	26-20
26-13	2870-2877	protein	abstract[150]|substance[152]	new[150]|giv[152]	_	_
26-14	2878-2882	InlF	abstract[150]|substance[152]	new[150]|giv[152]	_	_
26-15	2883-2884	,	_	_	_	_
26-16	2885-2892	showing	_	_	_	_
26-17	2893-2897	that	_	_	_	_
26-18	2898-2909	interaction	event[153]	new[153]	_	_
26-19	2910-2914	with	event[153]	new[153]	_	_
26-20	2915-2922	surface	event[153]|place|object[155]	new[153]|giv|new[155]	_	_
26-21	2923-2931	vimentin	event[153]|object[155]	new[153]|new[155]	_	_
26-22	2932-2935	was	_	_	_	_
26-23	2936-2944	required	_	_	_	_
26-24	2945-2948	for	_	_	_	_
26-25	2949-2951	an	abstract[156]	new[156]	_	_
26-26	2952-2959	optimal	abstract[156]	new[156]	_	_
26-27	2960-2975	colonialization	abstract[156]	new[156]	_	_
26-28	2976-2978	of	abstract[156]	new[156]	_	_
26-29	2979-2982	the	abstract[156]|object[157]	new[156]|giv[157]	_	_
26-30	2983-2988	brain	abstract[156]|object[157]	new[156]|giv[157]	_	_
26-31	2989-2990	.	_	_	_	_

#Text=The MAPK signaling cascade is activated during the invasion of L. monocytogenes .
27-1	2991-2994	The	abstract[160]	new[160]	_	_
27-2	2995-2999	MAPK	abstract|abstract[160]	new|new[160]	coref	28-18
27-3	3000-3009	signaling	abstract|abstract[160]	new|new[160]	coref	35-5
27-4	3010-3017	cascade	abstract[160]	new[160]	_	_
27-5	3018-3020	is	_	_	_	_
27-6	3021-3030	activated	_	_	_	_
27-7	3031-3037	during	_	_	_	_
27-8	3038-3041	the	event[161]	new[161]	coref	29-16[177_161]
27-9	3042-3050	invasion	event[161]	new[161]	_	_
27-10	3051-3053	of	event[161]	new[161]	_	_
27-11	3054-3056	L.	event[161]|person[162]	new[161]|giv[162]	coref	33-20[211_162]
27-12	3057-3070	monocytogenes	event[161]|person[162]	new[161]|giv[162]	_	_
27-13	3071-3072	.	_	_	_	_

#Text=In a model system of the BCSFB consisting of choroid plexus epithelial cells , the requirement of MAPK activation for listerial entry was demonstrated .
28-1	3073-3075	In	_	_	_	_
28-2	3076-3077	a	abstract[163]	new[163]	coref	29-20[179_163]
28-3	3078-3083	model	abstract[163]	new[163]	_	_
28-4	3084-3090	system	abstract[163]	new[163]	_	_
28-5	3091-3093	of	abstract[163]	new[163]	_	_
28-6	3094-3097	the	abstract[163]|abstract[164]	new[163]|giv[164]	coref	29-31[184_164]
28-7	3098-3103	BCSFB	abstract[163]|abstract[164]	new[163]|giv[164]	_	_
28-8	3104-3114	consisting	abstract[163]	new[163]	_	_
28-9	3115-3117	of	abstract[163]	new[163]	_	_
28-10	3118-3125	choroid	abstract[163]|object[166]	new[163]|giv[166]	ana	29-24[0_166]
28-11	3126-3132	plexus	abstract[163]|organization|object[166]	new[163]|new|giv[166]	_	_
28-12	3133-3143	epithelial	abstract[163]|object[166]	new[163]|giv[166]	_	_
28-13	3144-3149	cells	abstract[163]|object[166]	new[163]|giv[166]	_	_
28-14	3150-3151	,	_	_	_	_
28-15	3152-3155	the	abstract[167]	new[167]	_	_
28-16	3156-3167	requirement	abstract[167]	new[167]	_	_
28-17	3168-3170	of	abstract[167]	new[167]	_	_
28-18	3171-3175	MAPK	abstract[167]|abstract|abstract[169]	new[167]|giv|new[169]	coref|coref	35-1[219_169]|35-23
28-19	3176-3186	activation	abstract[167]|abstract[169]	new[167]|new[169]	_	_
28-20	3187-3190	for	abstract[167]	new[167]	_	_
28-21	3191-3200	listerial	abstract[167]|event[170]	new[167]|giv[170]	coref	32-21[203_170]
28-22	3201-3206	entry	abstract[167]|event[170]	new[167]|giv[170]	_	_
28-23	3207-3210	was	_	_	_	_
28-24	3211-3223	demonstrated	_	_	_	_
28-25	3224-3225	.	_	_	_	_

#Text=Both extracellular signal-regulated kinases ( ERK ) 1 and 2 and p38 inhibition resulted in decreased bacterial invasion into this model system suggesting their involvement in the pathogens traversal of the BCSFB .
29-1	3226-3230	Both	abstract[172]	new[172]	appos	29-6[0_172]
29-2	3231-3244	extracellular	abstract[172]	new[172]	_	_
29-3	3245-3261	signal-regulated	abstract|abstract[172]	new|new[172]	_	_
29-4	3262-3269	kinases	abstract[172]	new[172]	_	_
29-5	3270-3271	(	_	_	_	_
29-6	3272-3275	ERK	abstract	giv	appos	29-10
29-7	3276-3277	)	_	_	_	_
29-8	3278-3279	1	_	_	_	_
29-9	3280-3283	and	_	_	_	_
29-10	3284-3285	2	abstract	giv	_	_
29-11	3286-3289	and	_	_	_	_
29-12	3290-3293	p38	abstract|abstract[176]	new|new[176]	_	_
29-13	3294-3304	inhibition	abstract[176]	new[176]	_	_
29-14	3305-3313	resulted	_	_	_	_
29-15	3314-3316	in	_	_	_	_
29-16	3317-3326	decreased	event[177]	giv[177]	coref	33-20[212_177]
29-17	3327-3336	bacterial	event[177]	giv[177]	_	_
29-18	3337-3345	invasion	event[177]	giv[177]	_	_
29-19	3346-3350	into	event[177]	giv[177]	_	_
29-20	3351-3355	this	event[177]|abstract[179]	giv[177]|giv[179]	_	_
29-21	3356-3361	model	event[177]|person|abstract[179]	giv[177]|new|giv[179]	_	_
29-22	3362-3368	system	event[177]|abstract[179]	giv[177]|giv[179]	_	_
29-23	3369-3379	suggesting	_	_	_	_
29-24	3380-3385	their	object|abstract[181]	giv|giv[181]	coref	33-15[210_0]
29-25	3386-3397	involvement	abstract[181]	giv[181]	_	_
29-26	3398-3400	in	abstract[181]	giv[181]	_	_
29-27	3401-3404	the	abstract[181]|event[183]	giv[181]|new[183]	_	_
29-28	3405-3414	pathogens	abstract[181]|substance|event[183]	giv[181]|new|new[183]	coref	36-9[232_0]
29-29	3415-3424	traversal	abstract[181]|event[183]	giv[181]|new[183]	_	_
29-30	3425-3427	of	abstract[181]|event[183]	giv[181]|new[183]	_	_
29-31	3428-3431	the	abstract[181]|event[183]|abstract[184]	giv[181]|new[183]|giv[184]	ana	30-1[0_184]
29-32	3432-3437	BCSFB	abstract[181]|event[183]|abstract[184]	giv[181]|new[183]|giv[184]	_	_
29-33	3438-3439	.	_	_	_	_

#Text=It was previously described that ubiquitination of E-cadherin and Met leads to the recruitment of the clathrin-mediated endocytosis machinery .
30-1	3440-3442	It	abstract	giv	coref	33-11[208_0]
30-2	3443-3446	was	_	_	_	_
30-3	3447-3457	previously	_	_	_	_
30-4	3458-3467	described	_	_	_	_
30-5	3468-3472	that	_	_	_	_
30-6	3473-3487	ubiquitination	abstract[186]	new[186]	_	_
30-7	3488-3490	of	abstract[186]	new[186]	_	_
30-8	3491-3501	E-cadherin	abstract[186]|abstract	new[186]|giv	_	_
30-9	3502-3505	and	abstract[186]	new[186]	_	_
30-10	3506-3509	Met	abstract[186]|object	new[186]|giv	_	_
30-11	3510-3515	leads	_	_	_	_
30-12	3516-3518	to	_	_	_	_
30-13	3519-3522	the	event[189]	new[189]	ana	31-1[0_189]
30-14	3523-3534	recruitment	event[189]	new[189]	_	_
30-15	3535-3537	of	event[189]	new[189]	_	_
30-16	3538-3541	the	event[189]|object[192]	new[189]|giv[192]	_	_
30-17	3542-3559	clathrin-mediated	event[189]|abstract|object[192]	new[189]|new|giv[192]	_	_
30-18	3560-3571	endocytosis	event[189]|abstract|object[192]	new[189]|giv|giv[192]	coref	33-26[213_0]
30-19	3572-3581	machinery	event[189]|object[192]	new[189]|giv[192]	_	_
30-20	3582-3583	.	_	_	_	_

#Text=This in turn results in the polymerization of the actin cytoskeleton .
31-1	3584-3588	This	event	giv	_	_
31-2	3589-3591	in	_	_	_	_
31-3	3592-3596	turn	_	_	_	_
31-4	3597-3604	results	_	_	_	_
31-5	3605-3607	in	_	_	_	_
31-6	3608-3611	the	substance[194]	new[194]	_	_
31-7	3612-3626	polymerization	substance[194]	new[194]	_	_
31-8	3627-3629	of	substance[194]	new[194]	_	_
31-9	3630-3633	the	substance[194]|substance[196]	new[194]|new[196]	_	_
31-10	3634-3639	actin	substance[194]|abstract|substance[196]	new[194]|new|new[196]	coref	32-15
31-11	3640-3652	cytoskeleton	substance[194]|substance[196]	new[194]|new[196]	_	_
31-12	3653-3654	.	_	_	_	_

#Text=During this process , dynamin recruits several factors that result in two waves of actin rearrangements and subsequently result in the entry of the pathogen inside of vacuoles .
32-1	3655-3661	During	_	_	_	_
32-2	3662-3666	this	event[197]	new[197]	_	_
32-3	3667-3674	process	event[197]	new[197]	_	_
32-4	3675-3676	,	_	_	_	_
32-5	3677-3684	dynamin	substance	new	_	_
32-6	3685-3693	recruits	_	_	_	_
32-7	3694-3701	several	abstract[199]	giv[199]	_	_
32-8	3702-3709	factors	abstract[199]	giv[199]	_	_
32-9	3710-3714	that	abstract[199]	giv[199]	_	_
32-10	3715-3721	result	abstract[199]	giv[199]	_	_
32-11	3722-3724	in	abstract[199]	giv[199]	_	_
32-12	3725-3728	two	abstract[199]|abstract[200]	giv[199]|new[200]	_	_
32-13	3729-3734	waves	abstract[199]|abstract[200]	giv[199]|new[200]	_	_
32-14	3735-3737	of	abstract[199]|abstract[200]	giv[199]|new[200]	_	_
32-15	3738-3743	actin	abstract[199]|abstract[200]|abstract|event[202]	giv[199]|new[200]|giv|new[202]	coref	38-25
32-16	3744-3758	rearrangements	abstract[199]|abstract[200]|event[202]	giv[199]|new[200]|new[202]	_	_
32-17	3759-3762	and	abstract[199]	giv[199]	_	_
32-18	3763-3775	subsequently	abstract[199]	giv[199]	_	_
32-19	3776-3782	result	abstract[199]	giv[199]	_	_
32-20	3783-3785	in	_	_	_	_
32-21	3786-3789	the	event[203]	giv[203]	_	_
32-22	3790-3795	entry	event[203]	giv[203]	_	_
32-23	3796-3798	of	event[203]	giv[203]	_	_
32-24	3799-3802	the	event[203]|substance[204]	giv[203]|giv[204]	_	_
32-25	3803-3811	pathogen	event[203]|substance[204]	giv[203]|giv[204]	_	_
32-26	3812-3818	inside	event[203]	giv[203]	_	_
32-27	3819-3821	of	event[203]	giv[203]	_	_
32-28	3822-3830	vacuoles	event[203]|object	giv[203]|new	_	_
32-29	3831-3832	.	_	_	_	_

#Text=Accordingly , an in vitro study using a model of the BCSFB based on HIBCPP cells , revealed that L. monocytogenes invasion is inhibited if dynamin-mediated endocytosis is blocked .
33-1	3833-3844	Accordingly	_	_	_	_
33-2	3845-3846	,	_	_	_	_
33-3	3847-3849	an	abstract[206]	giv[206]	_	_
33-4	3850-3852	in	abstract[206]	giv[206]	_	_
33-5	3853-3858	vitro	abstract[206]	giv[206]	_	_
33-6	3859-3864	study	abstract[206]	giv[206]	_	_
33-7	3865-3870	using	abstract[206]	giv[206]	_	_
33-8	3871-3872	a	abstract[206]|abstract[207]	giv[206]|new[207]	_	_
33-9	3873-3878	model	abstract[206]|abstract[207]	giv[206]|new[207]	_	_
33-10	3879-3881	of	abstract[206]|abstract[207]	giv[206]|new[207]	_	_
33-11	3882-3885	the	abstract[206]|abstract[207]|abstract[208]	giv[206]|new[207]|giv[208]	_	_
33-12	3886-3891	BCSFB	abstract[206]|abstract[207]|abstract[208]	giv[206]|new[207]|giv[208]	_	_
33-13	3892-3897	based	abstract[206]|abstract[207]|abstract[208]	giv[206]|new[207]|giv[208]	_	_
33-14	3898-3900	on	abstract[206]|abstract[207]|abstract[208]	giv[206]|new[207]|giv[208]	_	_
33-15	3901-3907	HIBCPP	abstract[206]|abstract[207]|abstract[208]|substance|object[210]	giv[206]|new[207]|giv[208]|new|giv[210]	coref	38-9[247_210]
33-16	3908-3913	cells	abstract[206]|abstract[207]|abstract[208]|object[210]	giv[206]|new[207]|giv[208]|giv[210]	_	_
33-17	3914-3915	,	_	_	_	_
33-18	3916-3924	revealed	_	_	_	_
33-19	3925-3929	that	_	_	_	_
33-20	3930-3932	L.	person[211]|event[212]	giv[211]|giv[212]	coref	34-6[216_211]
33-21	3933-3946	monocytogenes	person[211]|event[212]	giv[211]|giv[212]	_	_
33-22	3947-3955	invasion	event[212]	giv[212]	_	_
33-23	3956-3958	is	_	_	_	_
33-24	3959-3968	inhibited	_	_	_	_
33-25	3969-3971	if	_	_	_	_
33-26	3972-3988	dynamin-mediated	abstract[213]	giv[213]	_	_
33-27	3989-4000	endocytosis	abstract[213]	giv[213]	_	_
33-28	4001-4003	is	_	_	_	_
33-29	4004-4011	blocked	_	_	_	_
33-30	4012-4013	.	_	_	_	_

#Text=Another essential virulence factor of L. monocytogenes is the pore-forming cytolysin Listeriolysin O ( LLO ) .
34-1	4014-4021	Another	abstract[215]	new[215]	coref	39-11[261_215]
34-2	4022-4031	essential	abstract[215]	new[215]	_	_
34-3	4032-4041	virulence	abstract|abstract[215]	new|new[215]	coref	39-14
34-4	4042-4048	factor	abstract[215]	new[215]	_	_
34-5	4049-4051	of	abstract[215]	new[215]	_	_
34-6	4052-4054	L.	abstract[215]|person[216]	new[215]|giv[216]	coref	36-5[231_216]
34-7	4055-4068	monocytogenes	abstract[215]|person[216]	new[215]|giv[216]	_	_
34-8	4069-4071	is	_	_	_	_
34-9	4072-4075	the	person[217]	new[217]	_	_
34-10	4076-4088	pore-forming	person[217]	new[217]	_	_
34-11	4089-4098	cytolysin	person[217]	new[217]	_	_
34-12	4099-4112	Listeriolysin	person[217]	new[217]	_	_
34-13	4113-4114	O	person[217]	new[217]	_	_
34-14	4115-4116	(	_	_	_	_
34-15	4117-4120	LLO	abstract	new	coref	35-8
34-16	4121-4122	)	_	_	_	_
34-17	4123-4124	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway by LLO was reported in the human embryonic kidney HEK-293 cell line , as well as MAPK signaling .
35-1	4125-4135	Activation	abstract[219]	giv[219]	_	_
35-2	4136-4138	of	abstract[219]	giv[219]	_	_
35-3	4139-4142	the	abstract[219]|abstract[222]	giv[219]|new[222]	coref	40-3[266_222]
35-4	4143-4148	NF-κB	abstract[219]|substance|abstract[222]	giv[219]|new|new[222]	coref	40-4
35-5	4149-4158	signaling	abstract[219]|abstract|abstract[222]	giv[219]|giv|new[222]	coref	35-23[229_0]
35-6	4159-4166	pathway	abstract[219]|abstract[222]	giv[219]|new[222]	_	_
35-7	4167-4169	by	abstract[219]	giv[219]	_	_
35-8	4170-4173	LLO	abstract[219]|abstract	giv[219]|giv	coref	37-14
35-9	4174-4177	was	_	_	_	_
35-10	4178-4186	reported	_	_	_	_
35-11	4187-4189	in	_	_	_	_
35-12	4190-4193	the	abstract[227]	new[227]	_	_
35-13	4194-4199	human	abstract[227]	new[227]	_	_
35-14	4200-4209	embryonic	place[224]|abstract[227]	new[224]|new[227]	_	_
35-15	4210-4216	kidney	place[224]|abstract[227]	new[224]|new[227]	_	_
35-16	4217-4224	HEK-293	time|abstract[227]	new|new[227]	_	_
35-17	4225-4229	cell	place|abstract[227]	giv|new[227]	coref	17-3
35-18	4230-4234	line	abstract[227]	new[227]	_	_
35-19	4235-4236	,	_	_	_	_
35-20	4237-4239	as	_	_	_	_
35-21	4240-4244	well	_	_	_	_
35-22	4245-4247	as	_	_	_	_
35-23	4248-4252	MAPK	abstract|abstract[229]	giv|giv[229]	ana	36-1[0_229]
35-24	4253-4262	signaling	abstract[229]	giv[229]	_	_
35-25	4263-4264	.	_	_	_	_

#Text=It is secreted by L. monocytogenes and promotes the pathogens intracellular survival .
36-1	4265-4267	It	abstract	giv	coref	40-5
36-2	4268-4270	is	_	_	_	_
36-3	4271-4279	secreted	_	_	_	_
36-4	4280-4282	by	_	_	_	_
36-5	4283-4285	L.	person[231]	giv[231]	coref	38-2[244_231]
36-6	4286-4299	monocytogenes	person[231]	giv[231]	_	_
36-7	4300-4303	and	_	_	_	_
36-8	4304-4312	promotes	_	_	_	_
36-9	4313-4316	the	substance[232]|event[233]	giv[232]|new[233]	_	_
36-10	4317-4326	pathogens	substance[232]|event[233]	giv[232]|new[233]	_	_
36-11	4327-4340	intracellular	event[233]	new[233]	_	_
36-12	4341-4349	survival	event[233]	new[233]	_	_
36-13	4350-4351	.	_	_	_	_

#Text=After entering the host cell , lysis of the vacuole is initiated through LLO and the bacterial phospholipases PlcA and PlcB , and followed by intracellular spread in the cytoplasm .
37-1	4352-4357	After	_	_	_	_
37-2	4358-4366	entering	_	_	_	_
37-3	4367-4370	the	place[235]	giv[235]	ana	38-33
37-4	4371-4375	host	animal|place[235]	giv|giv[235]	_	_
37-5	4376-4380	cell	place[235]	giv[235]	_	_
37-6	4381-4382	,	_	_	_	_
37-7	4383-4388	lysis	abstract[236]	new[236]	_	_
37-8	4389-4391	of	abstract[236]	new[236]	_	_
37-9	4392-4395	the	abstract[236]|object[237]	new[236]|new[237]	_	_
37-10	4396-4403	vacuole	abstract[236]|object[237]	new[236]|new[237]	_	_
37-11	4404-4406	is	_	_	_	_
37-12	4407-4416	initiated	_	_	_	_
37-13	4417-4424	through	_	_	_	_
37-14	4425-4428	LLO	abstract	giv	coref	40-15
37-15	4429-4432	and	_	_	_	_
37-16	4433-4436	the	abstract[239]	new[239]	_	_
37-17	4437-4446	bacterial	abstract[239]	new[239]	_	_
37-18	4447-4461	phospholipases	abstract[239]	new[239]	_	_
37-19	4462-4466	PlcA	abstract	new	_	_
37-20	4467-4470	and	_	_	_	_
37-21	4471-4475	PlcB	abstract	new	ana	38-13
37-22	4476-4477	,	_	_	_	_
37-23	4478-4481	and	_	_	_	_
37-24	4482-4490	followed	_	_	_	_
37-25	4491-4493	by	_	_	_	_
37-26	4494-4507	intracellular	event[242]	new[242]	coref	38-33[256_242]
37-27	4508-4514	spread	event[242]	new[242]	_	_
37-28	4515-4517	in	event[242]	new[242]	_	_
37-29	4518-4521	the	event[242]|place[243]	new[242]|new[243]	coref	38-6[245_243]
37-30	4522-4531	cytoplasm	event[242]|place[243]	new[242]|new[243]	_	_
37-31	4532-4533	.	_	_	_	_

#Text=Once L. monocytogenes has reached the cytoplasm of the host´s cells , it has been demonstrated to move around and enter neighboring cells using actin comet tails and membrane protrusions to facilitate its spread .
38-1	4534-4538	Once	_	_	_	_
38-2	4539-4541	L.	person[244]	giv[244]	_	_
38-3	4542-4555	monocytogenes	person[244]	giv[244]	_	_
38-4	4556-4559	has	_	_	_	_
38-5	4560-4567	reached	_	_	_	_
38-6	4568-4571	the	place[245]	giv[245]	_	_
38-7	4572-4581	cytoplasm	place[245]	giv[245]	_	_
38-8	4582-4584	of	place[245]	giv[245]	_	_
38-9	4585-4588	the	place[245]|object[247]	giv[245]|giv[247]	coref	38-22[249_247]
38-10	4589-4595	host´s	place[245]|animal|object[247]	giv[245]|new|giv[247]	_	_
38-11	4596-4601	cells	place[245]|object[247]	giv[245]|giv[247]	_	_
38-12	4602-4603	,	_	_	_	_
38-13	4604-4606	it	abstract	giv	_	_
38-14	4607-4610	has	_	_	_	_
38-15	4611-4615	been	_	_	_	_
38-16	4616-4628	demonstrated	_	_	_	_
38-17	4629-4631	to	_	_	_	_
38-18	4632-4636	move	_	_	_	_
38-19	4637-4643	around	_	_	_	_
38-20	4644-4647	and	_	_	_	_
38-21	4648-4653	enter	_	_	_	_
38-22	4654-4665	neighboring	object[249]	giv[249]	_	_
38-23	4666-4671	cells	object[249]	giv[249]	_	_
38-24	4672-4677	using	_	_	_	_
38-25	4678-4683	actin	abstract|object[251]|object[252]	giv|new[251]|new[252]	_	_
38-26	4684-4689	comet	object[251]|object[252]	new[251]|new[252]	_	_
38-27	4690-4695	tails	object[252]	new[252]	_	_
38-28	4696-4699	and	_	_	_	_
38-29	4700-4708	membrane	object|object[254]	giv|new[254]	_	_
38-30	4709-4720	protrusions	object[254]	new[254]	_	_
38-31	4721-4723	to	_	_	_	_
38-32	4724-4734	facilitate	_	_	_	_
38-33	4735-4738	its	place|event[256]	giv|giv[256]	coref	44-23[290_256]
38-34	4739-4745	spread	event[256]	giv[256]	_	_
38-35	4746-4747	.	_	_	_	_

#Text=This F-actin-based intracellular motility is dependent on the expression of another essential listerial virulence factor , ActA .
39-1	4748-4752	This	abstract[258]	new[258]	_	_
39-2	4753-4766	F-actin-based	abstract|abstract[258]	new|new[258]	_	_
39-3	4767-4780	intracellular	abstract[258]	new[258]	_	_
39-4	4781-4789	motility	abstract[258]	new[258]	_	_
39-5	4790-4792	is	_	_	_	_
39-6	4793-4802	dependent	_	_	_	_
39-7	4803-4805	on	_	_	_	_
39-8	4806-4809	the	abstract[259]	new[259]	_	_
39-9	4810-4820	expression	abstract[259]	new[259]	_	_
39-10	4821-4823	of	abstract[259]	new[259]	_	_
39-11	4824-4831	another	abstract[259]|abstract[261]	new[259]|giv[261]	appos	39-17[0_261]
39-12	4832-4841	essential	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
39-13	4842-4851	listerial	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
39-14	4852-4861	virulence	abstract[259]|abstract|abstract[261]	new[259]|giv|giv[261]	_	_
39-15	4862-4868	factor	abstract[259]|abstract[261]	new[259]|giv[261]	_	_
39-16	4869-4870	,	_	_	_	_
39-17	4871-4875	ActA	abstract	giv	_	_
39-18	4876-4877	.	_	_	_	_

#Text=Activation of the NF-κB signaling pathway is , as previously described , achieved through LLO .
40-1	4878-4888	Activation	event[263]	new[263]	_	_
40-2	4889-4891	of	event[263]	new[263]	_	_
40-3	4892-4895	the	event[263]|abstract[266]	new[263]|giv[266]	ana	41-6[0_266]
40-4	4896-4901	NF-κB	event[263]|substance|abstract[266]	new[263]|giv|giv[266]	coref	41-4
40-5	4902-4911	signaling	event[263]|abstract|abstract[266]	new[263]|giv|giv[266]	_	_
40-6	4912-4919	pathway	event[263]|abstract[266]	new[263]|giv[266]	_	_
40-7	4920-4922	is	_	_	_	_
40-8	4923-4924	,	_	_	_	_
40-9	4925-4927	as	_	_	_	_
40-10	4928-4938	previously	_	_	_	_
40-11	4939-4948	described	_	_	_	_
40-12	4949-4950	,	_	_	_	_
40-13	4951-4959	achieved	_	_	_	_
40-14	4960-4967	through	_	_	_	_
40-15	4968-4971	LLO	abstract	giv	_	_
40-16	4972-4973	.	_	_	_	_

#Text=Another mechanism involving NF-κB is its activation by InlC , which is secreted intracellularly .
41-1	4974-4981	Another	event[268]	giv[268]	coref	41-6[271_0]
41-2	4982-4991	mechanism	event[268]	giv[268]	_	_
41-3	4992-5001	involving	event[268]	giv[268]	_	_
41-4	5002-5007	NF-κB	event[268]|substance	giv[268]|giv	coref	43-13
41-5	5008-5010	is	_	_	_	_
41-6	5011-5014	its	abstract|event[271]	giv|giv[271]	coref	43-10[281_271]
41-7	5015-5025	activation	event[271]	giv[271]	_	_
41-8	5026-5028	by	event[271]	giv[271]	_	_
41-9	5029-5033	InlC	event[271]|substance[272]	giv[271]|new[272]	ana	42-1[0_272]
41-10	5034-5035	,	event[271]|substance[272]	giv[271]|new[272]	_	_
41-11	5036-5041	which	event[271]|substance[272]	giv[271]|new[272]	_	_
41-12	5042-5044	is	event[271]|substance[272]	giv[271]|new[272]	_	_
41-13	5045-5053	secreted	event[271]|substance[272]	giv[271]|new[272]	_	_
41-14	5054-5069	intracellularly	event[271]|substance[272]	giv[271]|new[272]	_	_
41-15	5070-5071	.	_	_	_	_

#Text=It can directly interact with the subunit of the IκB kinase complex , IKKα .
42-1	5072-5074	It	substance	giv	coref	44-1
42-2	5075-5078	can	_	_	_	_
42-3	5079-5087	directly	_	_	_	_
42-4	5088-5096	interact	_	_	_	_
42-5	5097-5101	with	_	_	_	_
42-6	5102-5105	the	abstract[274]	new[274]	_	_
42-7	5106-5113	subunit	abstract[274]	new[274]	_	_
42-8	5114-5116	of	abstract[274]	new[274]	_	_
42-9	5117-5120	the	abstract[274]|abstract[277]	new[274]|new[277]	appos	42-14[0_277]
42-10	5121-5124	IκB	abstract[274]|abstract|abstract[277]	new[274]|new|new[277]	coref	43-3
42-11	5125-5131	kinase	abstract[274]|object|abstract[277]	new[274]|giv|new[277]	_	_
42-12	5132-5139	complex	abstract[274]|abstract[277]	new[274]|new[277]	_	_
42-13	5140-5141	,	_	_	_	_
42-14	5142-5146	IKKα	abstract	giv	coref	43-5[280_0]
42-15	5147-5148	.	_	_	_	_

#Text=By phosphorylating IκB , this complex is critical for the activation of NF-κB , a major regulator of innate immune response .
43-1	5149-5151	By	_	_	_	_
43-2	5152-5167	phosphorylating	_	_	_	_
43-3	5168-5171	IκB	abstract	giv	coref	44-8
43-4	5172-5173	,	_	_	_	_
43-5	5174-5178	this	abstract[280]	giv[280]	_	_
43-6	5179-5186	complex	abstract[280]	giv[280]	_	_
43-7	5187-5189	is	_	_	_	_
43-8	5190-5198	critical	_	_	_	_
43-9	5199-5202	for	_	_	_	_
43-10	5203-5206	the	event[281]	giv[281]	_	_
43-11	5207-5217	activation	event[281]	giv[281]	_	_
43-12	5218-5220	of	event[281]	giv[281]	_	_
43-13	5221-5226	NF-κB	event[281]|substance	giv[281]|giv	appos	43-15[283_0]
43-14	5227-5228	,	_	_	_	_
43-15	5229-5230	a	substance[283]	giv[283]	_	_
43-16	5231-5236	major	substance[283]	giv[283]	_	_
43-17	5237-5246	regulator	substance[283]	giv[283]	_	_
43-18	5247-5249	of	substance[283]	giv[283]	_	_
43-19	5250-5256	innate	substance[283]|abstract[284]	giv[283]|new[284]	coref	44-13[289_284]
43-20	5257-5263	immune	substance[283]|abstract[284]	giv[283]|new[284]	_	_
43-21	5264-5272	response	substance[283]|abstract[284]	giv[283]|new[284]	_	_
43-22	5273-5274	.	_	_	_	_

#Text=InlC was shown to impair phosphorylation of IκB , thereby scaling down the hosts immune response , and is also involved in cell-to-cell spread .
44-1	5275-5279	InlC	substance	giv	_	_
44-2	5280-5283	was	_	_	_	_
44-3	5284-5289	shown	_	_	_	_
44-4	5290-5292	to	_	_	_	_
44-5	5293-5299	impair	_	_	_	_
44-6	5300-5315	phosphorylation	abstract[286]	new[286]	_	_
44-7	5316-5318	of	abstract[286]	new[286]	_	_
44-8	5319-5322	IκB	abstract[286]|abstract	new[286]|giv	_	_
44-9	5323-5324	,	_	_	_	_
44-10	5325-5332	thereby	_	_	_	_
44-11	5333-5340	scaling	_	_	_	_
44-12	5341-5345	down	_	_	_	_
44-13	5346-5349	the	abstract[289]	giv[289]	_	_
44-14	5350-5355	hosts	animal|abstract[289]	new|giv[289]	_	_
44-15	5356-5362	immune	abstract[289]	giv[289]	_	_
44-16	5363-5371	response	abstract[289]	giv[289]	_	_
44-17	5372-5373	,	_	_	_	_
44-18	5374-5377	and	_	_	_	_
44-19	5378-5380	is	_	_	_	_
44-20	5381-5385	also	_	_	_	_
44-21	5386-5394	involved	_	_	_	_
44-22	5395-5397	in	_	_	_	_
44-23	5398-5410	cell-to-cell	event[290]	giv[290]	_	_
44-24	5411-5417	spread	event[290]	giv[290]	_	_
44-25	5418-5419	.	_	_	_	_
